Cytokinetics Inc is categorized under Commercial Biotechnical Research in South San Francisco, CA .
Cytokinetics Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Robert Blum, Chief Executive Officer at the company’s headquarters by writing to 280 East Grand Avenue # 1, South San Francisco, California CA 94080 or by phoning (650) 624-3000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cytokinetics Inc |
| Contact Person: | Robert Blum, Chief Executive Officer |
| Address: | 280 East Grand Avenue # 1, South San Francisco, California 94080 |
| Phone Number: | (650) 624-3000 |
| Website Address: | cytokinetics.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417112 |
| Share This Business: |
Cytokinetics Inc was started in 0 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Robert Blum, Chief Executive Officer for inquiries that concern Cytokinetics Inc by calling the company number (650) 624-3000, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Cytokinetics Inc can be found at the coordinates 37.65287,-122.39458 as well as the street address 280 East Grand Avenue # 1 in South San Francisco, California 94080.
For its online presence, you may visit Cytokinetics Inc’s website at cytokinetics.com and engage with its social media outlets through on Twitter and on Facebook.